Literature DB >> 8492244

Lethal photosensitization by endogenous porphyrins of PAM cells--modification by desferrioxamine.

B Ortel1, A Tanew, H Hönigsmann.   

Abstract

The effects of exogenous delta-aminolevulinic acid (ALA) on cultured PAM 212 cells were investigated. PAM cells exposed to ALA produce an excess of products of the heme biosynthesis pathway within hours. The endogenous porphyrins render the cells photosensitive in a time-, ALA dose- and irradiation-dependent manner. Independently of the ALA-induced photosensitized processes, ALA itself reduces the proliferation rate of PAM cells during the exponential growth phase. Iron deprivation by addition of the chelating agent desferrioxamine (df) accelerates the photosensitizing process, and thus makes it more efficient at lower ALA concentrations. The effects of df were compared with the effects of manganese-df and iron-df. The results indicate that iron trapping is the most important factor for the potentiation of ALA-stimulated photodynamic sensitization as well as for the dark toxicity. Iron complexing agents may thus be used to optimize ALA effects in the photodynamic treatment of cutaneous neoplasms with endogenous porphyrins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8492244     DOI: 10.1016/1011-1344(93)80025-5

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  11 in total

Review 1.  The phototropin family as photoreceptors for blue light-induced chloroplast relocation.

Authors:  Takatoshi Kagawa
Journal:  J Plant Res       Date:  2002-12-21       Impact factor: 2.629

Review 2.  Chloroplast movement: dissection of events downstream of photo- and mechano-perception.

Authors:  Yoshikatsu Sato; Akeo Kadota; Masamitsu Wada
Journal:  J Plant Res       Date:  2003-01-11       Impact factor: 2.629

3.  Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma.

Authors:  Andrew Pye; Sandra Campbell; Alison Curnow
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-01       Impact factor: 4.553

Review 4.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

5.  Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.

Authors:  N Lange; P Jichlinski; M Zellweger; M Forrer; A Marti; L Guillou; P Kucera; G Wagnières; H van den Bergh
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

6.  Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures.

Authors:  A Casas; A M Batlle; A R Butler; D Robertson; E H Brown; A MacRobert; P A Riley
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

7.  The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid--a study on normal rat colon.

Authors:  A Curnow; S G Bown
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

8.  Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells.

Authors:  Ming-Jen Lee; Shih-Hsuan Hung; Mu-Ching Huang; Tsuimin Tsai; Chin-Tin Chen
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

9.  Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.

Authors:  B Ortel; N Chen; J Brissette; G P Dotto; E Maytin; T Hasan
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells.

Authors:  K Berg; H Anholt; O Bech; J Moan
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.